Silver sulfide (Ag 2 S) has gained widespread attention in second near-infrared (950–1700 nm, NIR-II) window imaging because of its high fluorescence quantum yield and low toxicity. However, its “always on” fluorescence shows inapplicability for targeted molecule-activated biomedical applications. Herein, we first developed a novel silver/silver sulfide Janus nanoparticle (Ag/Ag 2 S JNP) for specific activatable fluorescence imaging in the NIR-II window. Inner-particle electron compensation from Ag to Ag 2 S upon laser irradiation endowed JNPs an “off” state of fluorescence, whereas the oxidization of Ag incubated with H 2 O 2, decreasing the electron-transfer effect and illuminating the NIR-II fluorescence of the Ag 2 S part. In contrast, the absorption of Ag/Ag 2 S JNPs slightly decreased in an H 2 O 2 -dependent manner, showing an activated photoacoustic imaging mechanism. The Ag/Ag 2 S JNPs were used for noninvasive location and diagnosis of diseases in vivo, such as for liver injury and cancer, with high sensitivity and accuracy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: